# Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study

> **NCT07380919** · PHASE2,PHASE3 · RECRUITING · sponsor: **Federico II University** · enrollment: 100 (estimated)

## Conditions studied

- STEMI (ST Elevation MI)

## Interventions

- **DRUG:** Ranolazine

## Key facts

- **NCT ID:** NCT07380919
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07380919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07380919, "Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT07380919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*